RIZZOLIO, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.835
EU - Europa 5.963
AS - Asia 2.534
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 12
OC - Oceania 9
Totale 24.392
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.588
CN - Cina 2.229
IT - Italia 1.509
PL - Polonia 1.453
IE - Irlanda 651
UA - Ucraina 528
SE - Svezia 443
DE - Germania 404
GB - Regno Unito 267
CA - Canada 244
FR - Francia 174
RU - Federazione Russa 147
TR - Turchia 131
BE - Belgio 105
FI - Finlandia 82
AT - Austria 69
IN - India 34
IR - Iran 32
ES - Italia 29
NL - Olanda 25
CH - Svizzera 23
VN - Vietnam 21
JP - Giappone 20
PK - Pakistan 19
BJ - Benin 17
EU - Europa 17
UZ - Uzbekistan 14
GR - Grecia 13
BG - Bulgaria 11
KR - Corea 9
AU - Australia 8
CL - Cile 8
DK - Danimarca 6
RO - Romania 5
SI - Slovenia 5
CZ - Repubblica Ceca 4
SG - Singapore 4
TH - Thailandia 4
AL - Albania 3
BR - Brasile 3
MX - Messico 3
AM - Armenia 2
EG - Egitto 2
IL - Israele 2
MY - Malesia 2
NG - Nigeria 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EC - Ecuador 1
EE - Estonia 1
HK - Hong Kong 1
IQ - Iraq 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
Totale 24.392
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.154
Fairfield 2.163
Warsaw 1.448
Chandler 1.391
Ann Arbor 1.154
Houston 1.135
Seattle 878
Ashburn 863
Jacksonville 858
Cambridge 717
Wilmington 674
Dublin 584
Jinan 311
Mestre 262
Nanjing 248
Dearborn 228
Shenyang 218
Venezia 196
Andover 184
San Mateo 151
Mülheim 149
Boston 148
Hebei 139
Beijing 137
Izmir 129
Princeton 129
Venice 123
Ottawa 116
Toronto 115
San Diego 107
Brussels 103
Boardman 96
Guangzhou 95
Hangzhou 93
Tianjin 92
Changsha 87
Nanchang 86
Zhengzhou 86
Taizhou 83
Altamura 81
Haikou 77
Taiyuan 68
Ningbo 60
Vienna 55
Milan 53
Jiaxing 50
San Paolo di Civitate 50
Atlanta 48
Redwood City 42
London 41
Fuzhou 33
Des Moines 32
Menlo Park 31
Hefei 28
Saint Petersburg 28
Latiano 26
Washington 24
Helsinki 23
Bremen 21
Kunming 21
Dong Ket 20
Verona 20
Rome 19
Padova 18
Cotonou 17
Norwalk 17
Madrid 16
Moscow 16
Vicenza 15
Phoenix 13
Jesolo 11
Düsseldorf 10
Hanover 10
Lanzhou 10
Treviso 10
Vittorio Veneto 10
Palermo 9
Sofia 9
Tappahannock 9
Udine 9
Zanjan 9
Chiswick 8
Dolo 8
Portogruaro 8
Azzano Decimo 7
Chicago 7
Den Haag 7
Martellago 7
Reggio Nell'emilia 7
Amsterdam 6
Detroit 6
Eraclea 6
Henderson 6
Islamabad 6
Qingdao 6
Redmond 6
Southend 6
Tignale 6
Winnipeg 6
Auburn Hills 5
Totale 20.223
Salva come PNG Salva come JPEG
Nome #
Bottom-Up Synthesis of Carbon Nanoparticles with Higher Doxorubicin Efficacy 460
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 447
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 374
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activity on human ovarian cancer cell lines 373
Highly conserved non-coding sequences and the 18q critical region for short stature: A common mechanism of disease? 371
pRb controls estrogen receptor alpha protein stability and activity 367
Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications 358
Hyaluronan esters drive smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 358
Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer 340
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients 331
Palladacyclopentadienyl complexes bearing purine-based N-heterocyclic carbenes: A new class of promising antiproliferative agents against human ovarian cancer 330
Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer Cells 324
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor 322
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 321
DNA nanotechnology for cancer therapy 316
A guide to PIN1 function and mutations across cancers 309
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research 306
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 305
The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine 303
Carbon-dots from sugars and ascorbic acid: Role of the precursors on morphology, properties, toxicity and drug uptake 300
Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands 294
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 293
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 292
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer 284
An effective multi-stage liposomal DNA origami nanosystem for in vivo cancer therapy 284
The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer 271
Self-Therapeutic Nanomaterials for Cancer Therapy: A Review 270
Recent advances of electrochemical and optical enzyme-free glucose sensors operating at physiological conditions 263
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin 262
Highly Selective Salicylketoxime-Based Estrogen Receptor beta Agonists Display Antiproliferative Activities in a Glioma Model 247
Androgen receptor serine 81 mediates Pin1 interaction and activity 246
MTHFR-1298 A > C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 244
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 243
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 233
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) 231
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin 229
Adenosine receptor ligands in clinical trials 229
Identification and characterization of a new reversible MAGL inhibitor 227
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 226
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 226
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors 224
The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes 220
Epigenetic analysis of the critical region I for premature ovarian failure: Demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome 219
Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 219
Glucose Detection Devices and Methods Based on Metal–Organic Frameworks and Related Materials 219
RB gene family: Genome-wide ChIP approaches could open undiscovered roads 217
CDK inhibitors: from the bench to clinical trials 216
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 211
Pin1 and nuclear receptors: A new language? 210
Cyclic Ketoximes as Estrogen Receptor Selective Agonists 209
Spatial and temporal expression of POF1B, a gene expressed in epithelia 207
Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls 207
Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: A hypothesis 206
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 206
Critical choices for modeling breast cancer in transgenic mouse models 205
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 205
Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells 204
Dissecting Pin1 and phospho-pRb regulation 203
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines 199
Fluorescent carbon nanoparticles in medicine for cancer therapy 198
A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males 196
Identification of new fyn kinase inhibitors using a FLAP-based approach 195
A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28 195
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models 194
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 193
Emerging molecular networks in Burkitt's lymphoma 192
Chromosomal rearrangements in Xq and premature ovarian failure: Mapping of 25 new cases and review of the literature 192
Improved Synthesis, Anticancer Activity and Electrochemical Characterization of Unusual Zwitterionic Palladium Compounds with a Ten‐Term Coordinative Ring 192
Pharmaco-metabolomics: An emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets 190
Metabolomics biomarkers of frailty in elderly breast cancer patients 189
Fluorescent molecularly imprinted nanogels for the detection of anticancer drugs in human plasma 189
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 187
Nanomedicine in cancer pathology 185
Supercritical CO2 extraction of natural antibacterials from low value weeds and agro-waste 182
Allyl palladium complexes bearing carbohydrate-based N-heterocyclic carbenes: Anticancer agents for selective and potent in vitro cytotoxicity 182
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 179
X chromosome and ovarian failure 179
Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells 176
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors 175
Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update 170
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt's lymphoma cell lines 169
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B 168
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 167
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 166
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease 161
Inorganic Nanoparticles for Cancer Therapy: a Transition from Lab to Clinic 160
Rational development of MAGL inhibitors 158
Palladium(II)-η3-Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids 158
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer 157
Research highlights. Protein kinase D3 is the genetic sensitizer of RAF inhibitor RAF265 in melanoma cells 156
Research highlights. Overcoming BRAF resistance to PLX4032 by AKT inhibition in PTEN-deficient melanoma cells 156
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors 155
Synthesis and Antimicrobial Evaluation of Bis-morpholine Triazine Quaternary Ammonium Salts 149
Cancer extracellular vesicles: Next-generation diagnostic and drug delivery nanotools 144
Research highlights. MCL1 and FBW7 as new predictive candidate biomarkers of anti-tubulin agents 143
Upconversion-mediated Boltzmann thermometry in double-layered Bi2SiO5:Yb3+,Tm3+@SiO2hollow nanoparticles 138
Research highlights. PI3K/AKT/mTOR inhibitors would require PI3KCA-mutation analysis 136
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer 135
Sustainable triazine-derived quaternary ammonium salts as antimicrobial agents 132
Application of MM-PBSA methods in virtual screening 129
Totale 22.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.087 0 0 185 171 239 72 55 62 68 210 402 623
2019/20205.611 417 354 398 1.358 372 486 371 647 400 434 221 153
2020/20214.930 251 172 283 222 810 410 415 396 288 598 663 422
2021/20225.040 344 591 330 625 383 40 221 194 97 740 1.014 461
2022/20234.014 297 384 68 445 366 1.110 73 368 492 37 294 80
2023/2024296 106 116 74 0 0 0 0 0 0 0 0 0
Totale 25.045